Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

HLVX

HilleVax (HLVX)

HilleVax Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:HLVX
일자시간출처헤드라인심볼기업
2024/12/0606:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/11/0722:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
2024/11/0722:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/11/0722:00GlobeNewswire Inc.HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
2024/10/1705:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/08/0908:20GlobeNewswire Inc.HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
2024/08/0105:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/08/0105:00GlobeNewswire Inc.HilleVax Announces Reduction in ForceNASDAQ:HLVXHilleVax Inc
2024/07/2405:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/07/0919:54IH Market NewsBP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More NewsNASDAQ:HLVXHilleVax Inc
2024/07/0820:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/07/0820:30GlobeNewswire Inc.HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in InfantsNASDAQ:HLVXHilleVax Inc
2024/06/1105:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/05/1013:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:HLVXHilleVax Inc
2024/05/1005:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HLVXHilleVax Inc
2024/05/1005:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/05/1005:05GlobeNewswire Inc.HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
2024/03/2105:00GlobeNewswire Inc.HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company ProgressNASDAQ:HLVXHilleVax Inc
2024/02/1309:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
2024/02/0606:05GlobeNewswire Inc.HilleVax to Present at Guggenheim 6th Annual Biotechnology ConferenceNASDAQ:HLVXHilleVax Inc
2024/02/0306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
2024/01/2707:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
2024/01/1821:49Dow Jones NewsHilleVax Taps Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
2024/01/1821:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/01/1821:00GlobeNewswire Inc.HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating OfficerNASDAQ:HLVXHilleVax Inc
2024/01/0821:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HLVXHilleVax Inc
2024/01/0821:00GlobeNewswire Inc.HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of ChinaNASDAQ:HLVXHilleVax Inc
2024/01/0408:28GlobeNewswire Inc.HilleVax to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:HLVXHilleVax Inc
2023/12/1907:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HLVXHilleVax Inc
2023/12/1907:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HLVXHilleVax Inc
 검색 관련기사 보기:NASDAQ:HLVX